NCT04508413View on ClinicalTrials.gov

A Clinical Study to Assess the Effects of KB295 in Patients With Ulcerative Colitis (UC) on Gut Microbiota Structure and Function

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

August 12, 2020

Primary Completion Date

November 29, 2021

Study Completion Date

November 29, 2021

Conditions
Ulcerative Colitis
Interventions
OTHER

KB295

KB295 is a novel glycan

Trial Locations (3)

60611

Atlantia Food Clinical Trials, Chicago

78738

Elligo Health Research, Inc., Austin

T23 R50R

Atlantia Food Clinical Trials, Cork

Sponsors
All Listed Sponsors
lead

Kaleido Biosciences

INDUSTRY